Merck   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: New York NY United States (1917)

Organization Overview

First Clinical Trial
1983
NCT00222664
First Marketed Drug
1925
urea
First NDA Approval
1925
urea
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Dey LP | Dey, L.P. | Dey Pharma, L.P. | Fulford India Limited | LLC Merck, Russia | MERCK | Merck A.B., Sweden | Merck A.E., Greece | MERCK AND CO INC | Merck A/S, Denmark | Merck B.V., Netherlands | Merck Canada Inc | Merck Canada Inc. | Merck Frosst Canada Ltd. | Merck Frosst-Schering Pharma, G.P. | Merck Gesellschaft mbH, Austria | Merck Inc., Philippines | Merck Institute for Therapeutic Research | Merck Ltd. | Merck Ltd., India | Merck Ltd., Taiwan | Merck N.V.-S.A., Belgium | Merck OY, Finland | Merck/Pfizer | Merck Pharma, K.S., Slovakia | Merck Pte. Ltd., Singapore | Merck S.A. de C.V., Mexico | Merck Sante S.A.S. France | Merck, S.A., Portugal | Merck Schering-Plough | MERCK SHARP DOHME | Merck Sharp & Dohme (Australia) Pty Limited | Merck Sharp & Dohme (Australia) Pty Ltd | Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Ltd | Merck Sharp & Dohme (MSD) | Merck, Sharpe & Dohme Corp. | Merck Shering-Plough JV Study | Merck, S.L., Spain | Merck spol.s.r.o., Czech Republic | Merck spol. s r.o., Slovakia | Merck SP. Z.O.O., Poland | Merck Women's Health Investigator Initiated Studies Program | MSD Belgium BVBA | MSD France | MSD INTL | MSD INTL GMBH | MSD K.K. | MSD Korea Ltd. | MSD MERCK CO | MSD SHARP and DOHME GMBH Haar Germany | MSD SHARP & DOHME GmbH (formerly Essex Pharma GmbH) | MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. | MSI | Raltegravir is provided by Merck. | TeleRx | Vlaams Instituut voor Biotechnologie (VIB); Merck Sharp & Dohme (MSD)